Literature DB >> 21836304

Biocompatible polymeric micelles with polysorbate 80 for use in brain targeting.

E F Craparo1, M C Ognibene, M P Casaletto, G Pitarresi, G Teresi, G Giammona.   

Abstract

In this paper, the synthesis and characterization of novel amphiphilic graft copolymers based on an α,β-poly(N-2-hydroxyethyl)-D,L-aspartamide (PHEA) backbone and D,L-polylactic acid (PLA) hydrophobic side chains are reported. These copolymers were obtained starting from PHEA-ethylenediamine (PHEA-EDA), which was functionalized with polysorbate 80 (PS(80)) and/or PLA in order to obtain the PHEA-EDA-PS(80)-PLA and PHEA-EDA-PLA samples, respectively. The degrees of derivatization, DD(PS80) and DD(PLA), of PHEA-EDA-PS(80)-PLA, calculated by (1)H-NMR, resulted in being 1.2 ± 0.03 mol% and 0.54 ± 0.05 mol%, respectively, while that of PHEA-EDA-PLA was found to be 0.60 ± 0.05 mol%. Size exclusion chromatography (SEC) analysis confirmed the occurrence of derivatization, the molecular weight values being close to the theoretical ones. Polymeric micelles from PHEA-EDA-PLA and PHEA-EDA-PS(80)-PLA copolymers were obtained by using the dialysis method and were characterized in terms of mean size, zeta potential, critical aggregation concentration (CAC), and surface composition by x-ray photoelectron spectroscopy (XPS) analysis, which demonstrated the presence of PS(80) onto the PHEA-EDA-PS(80)-PLA micelle surface. In vitro experiments demonstrated that these systems had no cytotoxic effects on 16 HBE, Caco2, HuDe and K562 cell lines, and no haemolytic activity. Moreover, both PHEA-EDA-PS(80)-PLA and PHEA-EDA-PLA micelles were able to penetrate into Neuro2a cells and, in the case of PS(80) decorated micelles, to escape from phagocytosis by the J774 A1 macrophages.

Entities:  

Year:  2008        PMID: 21836304     DOI: 10.1088/0957-4484/19/48/485603

Source DB:  PubMed          Journal:  Nanotechnology        ISSN: 0957-4484            Impact factor:   3.874


  4 in total

Review 1.  Nanoparticulate systems for drug delivery and targeting to the central nervous system.

Authors:  Emanuela Fabiola Craparo; Maria Luisa Bondì; Giovanna Pitarresi; Gennara Cavallaro
Journal:  CNS Neurosci Ther       Date:  2010-10-15       Impact factor: 5.243

2.  Ellipsoidal Polyaspartamide Polymersomes with Enhanced Cell-Targeting Ability.

Authors:  Mei-Hsiu Lai; Jae Hyun Jeong; Ross J Devolder; Christopher Brockman; Charles Schroeder; Hyunjoon Kong
Journal:  Adv Funct Mater       Date:  2012-08-07       Impact factor: 18.808

Review 3.  Nanoplatforms for constructing new approaches to cancer treatment, imaging, and drug delivery: what should be the policy?

Authors:  Babak Kateb; Katherine Chiu; Keith L Black; Vicky Yamamoto; Bhavraj Khalsa; Julia Y Ljubimova; Hui Ding; Rameshwar Patil; Jose Antonio Portilla-Arias; Mike Modo; David F Moore; Keyvan Farahani; Michael S Okun; Neal Prakash; Josh Neman; Daniel Ahdoot; Warren Grundfest; Shouleh Nikzad; John D Heiss
Journal:  Neuroimage       Date:  2010-02-10       Impact factor: 7.400

4.  Oral delivery of lycopene-loaded microemulsion for brain-targeting: preparation, characterization, pharmacokinetic evaluation and tissue distribution.

Authors:  Yunliang Guo; Xuyan Mao; Jing Zhang; Peng Sun; Haiyang Wang; Yue Zhang; Yingjuan Ma; Song Xu; Renjun Lv; Xueping Liu
Journal:  Drug Deliv       Date:  2019-12       Impact factor: 6.419

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.